Overview
Yasuji Miyakita practices in Tokyo, Japan. Miyakita is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. Their top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, Astrocytoma, and Awake Craniotomy.
Their clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Metastatic Brain Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GliomaMiyakita isDistinguished. Learn about Glioma.
- Gliomatosis CerebriMiyakita isDistinguished. Learn about Gliomatosis Cerebri.
- Advanced
- AstrocytomaMiyakita isAdvanced. Learn about Astrocytoma.
- Brain TumorMiyakita isAdvanced. Learn about Brain Tumor.
- GlioblastomaMiyakita isAdvanced. Learn about Glioblastoma.
- Metastatic Brain TumorMiyakita isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- Adult Soft Tissue SarcomaMiyakita isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerMiyakita isExperienced. Learn about Anal Cancer.
- Awake CraniotomyMiyakita isExperienced. Learn about Awake Craniotomy.
- Ear CancerMiyakita isExperienced. Learn about Ear Cancer.
- Low Sodium LevelMiyakita isExperienced. Learn about Low Sodium Level.
- OligodendrogliomaMiyakita isExperienced. Learn about Oligodendroglioma.